Barlow, DH (2002). Anxiety and its disorders (2nd ed.). New York, NY: Guilford Press.
Crawford, JR, Garthwaite, PH, Lawrie, CJ, Henry, JD, MacDonald, MA, Sutherland, J … Sinha, P (2009). A convenient method of obtaining percentile norms and accompanying interval estimates for self-report mood scales (DASS, DASS-21, HADS, PANAS, and sAD). British Journal of Clinical Psychology, 48, 163–180.
Cuijpers, P, van Straten, A and Warmerdam, L (2007). Behavioral activation treatments of depression: A meta-analysis. Clinical Psychology Review, 27, 318–326.
Dobson, KS, Hollon, SD, Dimidjian, S, Schmaling, KB, Kohlenberg, RJ, Gallop, RJ … Jacobson, NS (2008). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Journal of Consulting and Clinical Psychology, 76, 468–477.
Dunlap, WP, Cortina, JM, Vaslow, JB and Burke, MJ (1996). Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods, 1, 170–177.
Engin, B, Uguz, F, Yilmaz, E, Özdemir, M and Mevlitoglu, I (2008). The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology, 22, 36–40.
Evans, C, Margison, F and Barkham, M (1998). The contribution of reliable and clinically significant change methods to evidence-based mental health. Evidence-Based Mental Health, 1, 70–72.
Ferrer, M (2015). Immunological events in chronic spontaneous urticaria. BMC Clinical and Translational Allergy, 5, 30.
Ferster, CB (1973). A functional analysis of depression. American Psychologist, 28, 857–890.
Gawrysiak, M, Nicholas, C and Hopko, DR (2009). Behavioral activation for moderately depressed university students: Randomized controlled trial. Journal of Counseling Psychology, 56, 468–475.
Grattan, CE, Sabroe, RA and Greaves, MW (2002). Chronic urticaria. Journal of the American Academy of Dermatology, 46, 645–660.
Gupta, MA and Gupta, AK (2003). Psychiatric and psychological co-morbidity in patients with dermatologic disorders. American Journal of Clinical Dermatology, 4, 833–842.
Hergüner, S, Kılıç, G, Karakoc, S, Tamay, Z, Tüzün, Ü and Güler, N (2011). Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria. British Journal of Dermatology, 164, 1342–1347.
Hopko, DR, Lejuez, CW, Ruggiero, KJ and Eifert, GH (2003). Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. Clinical Psychology Review, 23, 699–717.
Jacobson, NS and Truax, P (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12–19.
Kanter, JW, Mulick, PS, Busch, AM, Berlin, KS and Martell, CR (2006). The Behavioral Activation for Depression Scale (BADS): Psychometric properties and factor structure. Journal of Psychopathology and Behavioral Assessment, 29, 191–202.
Kroenke, K, Spitzer, RL and Williams, JB (2001). The PHQ-9. Journal of General Internal Medicine, 16, 606–613.
Lejuez, CW, Hopko, DR, Acierno, R, Daughters, SB and Pagoto, SL (2011). Ten year revision of the brief behavioral activation treatment for depression: Revised treatment manual. Behavior Modification, 35, 111–161.
Lejuez, CW, Hopko, DR and Hopko, SD (2001). A brief behavioral activation treatment for depression treatment manual. Behavior Modification, 25, 255–286.
Lovibond, SH and Lovibond, PF (1995). Manual for the Depression Anxiety Stress Scales (2nd ed.). Sydney, Australia: Psychology Foundation of Australia.
Martell, CR, Addis, ME and Jacobson, NS (2001). Depression in context: Strategies for guided action. New York, NY: WW Norton and Co.
Özkan, M, Oflaz, SB, Kocaman, N, Özşeker, F, Gelincik, A, Büyüköztürk, S … Çolakoğlu, B (2007). Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Annals of Allergy, Asthma & Immunology, 99, 29–33.
Roemer, L (2001). Measures for anxiety and related constructs. Antony, MM, Orsillo, SM and Roemer, L (Eds.), Practitioner's guide to empirically based measures of anxiety (pp. 49–83). New York, NY: Guilford Press.
Shenefelt, PD (2010). Psychological interventions in the management of common skin conditions. Psychology Research and Behavior Management, 3, 51–63.
Staubach, P, Eckhardt-Henn, A, Dechene, M, Vonend, A, Metz, M, Magerl, M … Maurer, M (2006). Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. British Journal of Dermatology, 154, 294–298.
Takahagi, S, Mihara, S, Iwamoto, K, Morioke, S, Okabe, T, Kameyoshi, Y and Hide, M (2010). Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy, 65, 649–656.
Tull, MT, Berghoff, CR, Bardeen, JR, Schoenleber, M and Konkle-Parker, DJ (2018). An initial open trial of a brief behavioral activation treatment for depression and medication adherence in HIV-infected patients. Behavior Modification, 42, 196–209.
Weller, K, Groffik, A, Church, MK, Hawro, T, Krause, K, Metz, M … Maurer, M (2014). Development and validation of the urticarial control test: A patient-reported outcome instrument for assessing urticarial control. The Journal of Allergy and Clinical Immunology, 133, 1365–1372.
Weller, K, Viehmann, K, Bräutigam, M, Krause, K, Siebenhaar, F, Zuberbier, T and Maurer, M (2012). Cost-intensive, time-consuming, problematical? How physicians in private practice experience the care of urticaria patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 10, 341–347.